Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Slow Capital Inc.

Slow Capital Inc. raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 40,660 shares of the medical equipment provider’s stock after purchasing an additional 28 shares during the period. Intuitive Surgical accounts for approximately 3.0% of Slow Capital Inc.’s holdings, making the stock its 8th biggest holding. Slow Capital Inc.’s holdings in Intuitive Surgical were worth $21,223,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of ISRG. AQR Capital Management LLC grew its stake in Intuitive Surgical by 12.6% in the second quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider’s stock valued at $18,958,000 after acquiring an additional 4,775 shares during the period. Creative Planning grew its position in shares of Intuitive Surgical by 9.8% in the 2nd quarter. Creative Planning now owns 63,039 shares of the medical equipment provider’s stock valued at $28,043,000 after purchasing an additional 5,629 shares during the period. NewEdge Advisors LLC increased its stake in Intuitive Surgical by 8.2% during the 2nd quarter. NewEdge Advisors LLC now owns 13,825 shares of the medical equipment provider’s stock worth $6,150,000 after purchasing an additional 1,044 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in Intuitive Surgical by 2.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 20,458 shares of the medical equipment provider’s stock worth $9,100,000 after buying an additional 411 shares during the period. Finally, Wellington Wealth Strategies LLC. bought a new position in Intuitive Surgical in the second quarter valued at approximately $241,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on ISRG. UBS Group increased their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday. Truist Financial increased their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday. Mizuho boosted their price target on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Finally, Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 42,265 shares of company stock valued at $21,964,281. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Down 1.8 %

Intuitive Surgical stock opened at $573.48 on Tuesday. The company has a market capitalization of $204.26 billion, a price-to-earnings ratio of 92.20, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock’s 50 day moving average is $547.16 and its 200-day moving average is $505.21.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.